From the Desk of Kimmy Sokoloff

After the first hour of trading we were mostly flat.

The Fed did what it had to do, and now we'll watch the markets.

We may have stumbled upon an underpriced opportunity, one that must be off the radar of most traders because it's practically jumping off the screen at us.

It's an international banking name with speculative exposure to China, yet the DNA of old-money British aristocrats.

And we're breaking out today!

Here's a recent chart of HSBC Holdings PLC $HSBC:

What you don't see on this chart is $HSBC breaking out above that resistance level today. As I type this, the stock traded as high as $39.14.

We've adjusted a position in the Paid-to-Play portfolio today:

Congratulations to the 2023 NBA Champion Denver Nuggets!

I’m a total bandwagoner, having never watched a Nuggets game in the eleven years I’ve now lived in Colorado. My first Nuggets watch was the first playoff game this year. And I watched every game the rest of the way.

My timing was pretty good.

What has stood out the most to me in the interviews and press I saw and read last night and this morning following the Nuggets win is how their journey to the top required tremendous patience and a focus on their edge.

And more patience. More sharpening of the edge. And then a little more of both after that.

The Nuggets organization knew they were building a winner. But it would take time. Time for the stars to develop. Time for injuries to heal. Time for missing pieces to be added. And time for the stars to align.

The most significant transaction on today's list comes in a Form 4 filing by Ryan Cohen, executive chairman of GameStop $GME.

Cohen revealed a purchase of 443,842 GME shares, equivalent to roughly $10 million.

From the Desk of Kimmy Sokoloff

We've got the Fed today, and let's say we sell off.

Even so, it would be a much needed consolidation.

How's the Bull Market treating you so far?

Can you believe it's been a year already since the new 52-week lows list peaked?

Remember, the first thing stocks need to do before they can start to go up in price, is to stop going down!

That happened 1-year ago.

Since then Technology, Communications, Consumer Discretionary and Industrials are all up over 20%. Tech is up almost 40%.

Meanwhile, Healthcare and Financials are each up 10% during this period.

And then some of the more defensive sectors, like Staples and Utilities, are up, but very much underperforming the more offensive sectors.

This is all perfectly normal behavior in bull markets, so we're not surprised at all. No one should...

They've been telling me for almost a year that this is just a bear market rally.

If you're one of those people, I would ask your therapist about it.

The New Lows list peaked last June.

It's been steady improvement and sector rotation ever since.

This month is just the latest example. We now started to get rotation into Small-caps.

See: Bullish Risk Reversal In Small-caps (May 2023)

I'm convinced the world needs more bubble charts. There just aren't enough.

So here at...

From the Desk of Kimmy Sokoloff

The market was happy with the CPI numbers.

No rest for the weary...

From the Desk of Ian Culley @IanCulley

Markets are bracing for tomorrow’s FOMC decision – including the dollar.

That’s right – we have more indecisive action on tap. Let’s call it the knee-jerk before the knee-jerk, with a little help from today’s May CPI print. 

Interest rates, the US Dollar Index $DXY, and gold have yet to make a decisive directional move.

To be fair, most markets are trading within their respective year-to-date ranges (except the S&P 500 and Nasdaq 100, of course).

But if we turn to emerging market currencies, we don’t see any sign of hesitation…

Check out our EM Commodity Currency Index (equally weighting the Mexican peso, the Brazilian real, the Chilean peso, and the South African rand) posting new 52-week highs after violating a long-term downtrend line at the beginning of the year:

...

We've adjusted a position in the Paid-to-Play portfolio today:

The most significant transaction on today's list comes in a Form 4 filing by Len Blavatnik.

Blavatnik reported a purchase of $10 million in Day One Biopharmaceuticals $DAWN.